PYCR2
Basic information
Region (hg38): 1:225919877-225924340
Links
Phenotypes
GenCC
Source:
- autosomal recessive primary microcephaly (Supportive), mode of inheritance: AR
- hypomyelinating leukodystrophy 10 (Definitive), mode of inheritance: AR
- hypomyelinating leukodystrophy 10 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Leukodystrophy, hypomyelinating 10 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic | 25865492 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (5 variants)
- Hypomyelinating leukodystrophy 10 (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PYCR2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 26 | 30 | ||||
missense | 36 | 44 | ||||
nonsense | 4 | |||||
start loss | 2 | |||||
frameshift | 6 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 5 | |||||
splice region | 1 | 3 | 1 | 5 | ||
non coding | 12 | |||||
Total | 6 | 15 | 42 | 34 | 7 |
Highest pathogenic variant AF is 0.0000263
Variants in PYCR2
This is a list of pathogenic ClinVar variants found in the PYCR2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-225920477-G-C | not specified | Benign (Apr 10, 2023) | ||
1-225920494-G-C | not specified • Hypomyelinating leukodystrophy 10 | Benign/Likely benign (Jan 08, 2024) | ||
1-225920500-C-T | Benign (Jan 29, 2024) | |||
1-225920520-G-C | Inborn genetic diseases | Uncertain significance (Jan 27, 2022) | ||
1-225920541-C-A | Uncertain significance (Aug 02, 2022) | |||
1-225920552-C-T | Inborn genetic diseases | Uncertain significance (Dec 03, 2021) | ||
1-225920577-C-T | Inborn genetic diseases | Uncertain significance (Jun 03, 2024) | ||
1-225920601-C-G | Uncertain significance (Jul 15, 2022) | |||
1-225920617-C-T | Likely benign (Sep 01, 2022) | |||
1-225921192-C-T | Uncertain significance (Dec 02, 2021) | |||
1-225921194-C-T | Hypomyelinating leukodystrophy 10 | Benign (Jan 30, 2024) | ||
1-225921199-T-G | Hypomyelinating leukodystrophy 10 | Benign (Jan 30, 2024) | ||
1-225921209-G-A | Hypomyelinating leukodystrophy 10 | Pathogenic (Sep 01, 2022) | ||
1-225921219-A-C | Uncertain significance (Sep 07, 2022) | |||
1-225921220-CAGG-C | Uncertain significance (Dec 08, 2021) | |||
1-225921232-A-G | Hypomyelinating leukodystrophy 10 | Likely pathogenic (Mar 20, 2024) | ||
1-225921243-G-A | Likely benign (Nov 29, 2017) | |||
1-225921246-C-CAG | Hypomyelinating leukodystrophy 10 | Pathogenic/Likely pathogenic (Nov 13, 2023) | ||
1-225921253-C-T | Hypomyelinating leukodystrophy 10 | Conflicting classifications of pathogenicity (-) | ||
1-225921254-G-A | Hypomyelinating leukodystrophy 10 | Pathogenic (May 07, 2015) | ||
1-225921257-A-C | Hypomyelinating leukodystrophy 10 | Uncertain significance (May 21, 2021) | ||
1-225921258-G-A | Likely benign (Jul 17, 2023) | |||
1-225921260-C-G | Uncertain significance (Jun 05, 2022) | |||
1-225921294-G-T | Likely benign (Apr 10, 2022) | |||
1-225921311-A-C | Hypomyelinating leukodystrophy 10 | Pathogenic (Sep 16, 2016) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PYCR2 | protein_coding | protein_coding | ENST00000343818 | 7 | 4401 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000207 | 0.476 | 125720 | 0 | 28 | 125748 | 0.000111 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.948 | 156 | 193 | 0.808 | 0.0000109 | 2053 |
Missense in Polyphen | 34 | 61.079 | 0.55665 | 639 | ||
Synonymous | -0.520 | 92 | 85.9 | 1.07 | 0.00000542 | 691 |
Loss of Function | 0.685 | 10 | 12.6 | 0.792 | 7.21e-7 | 135 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000729 | 0.000728 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.0000619 | 0.0000615 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Housekeeping enzyme that catalyzes the last step in proline biosynthesis. In some cell types, such as erythrocytes, its primary function may be the generation of NADP(+). Can utilize both NAD and NADP. Has higher affinity for NADP, but higher catalytic efficiency with NADH (PubMed:2722838, PubMed:6894153). Involved in cellular response to oxidative stress (PubMed:25865492). {ECO:0000269|PubMed:25865492, ECO:0000269|PubMed:2722838, ECO:0000269|PubMed:6894153}.;
- Pathway
- Arginine and proline metabolism - Homo sapiens (human);Hyperornithinemia with gyrate atrophy (HOGA);Creatine deficiency, guanidinoacetate methyltransferase deficiency;L-arginine:glycine amidinotransferase deficiency;Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome];Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency);Prolinemia Type II;Prolidase Deficiency (PD);Arginine and Proline Metabolism;Hyperprolinemia Type I;Hyperprolinemia Type II;Ornithine Aminotransferase Deficiency (OAT Deficiency);Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency);Metabolism of amino acids and derivatives;Metabolism;proline biosynthesis;Amino acid synthesis and interconversion (transamination)
(Consensus)
Recessive Scores
- pRec
- 0.162
Intolerance Scores
- loftool
- 0.338
- rvis_EVS
- -0.71
- rvis_percentile_EVS
- 14.4
Haploinsufficiency Scores
- pHI
- 0.201
- hipred
- N
- hipred_score
- 0.146
- ghis
- 0.618
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.969
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pycr2
- Phenotype
- immune system phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- proline biosynthetic process;cellular amino acid biosynthetic process;cellular response to oxidative stress;oxidation-reduction process;L-proline biosynthetic process
- Cellular component
- mitochondrion;mitochondrial matrix
- Molecular function
- pyrroline-5-carboxylate reductase activity;protein binding